MacroGenics, Inc.

NASDAQ:MGNX

Biotechnology

Healthcare
$1.97 +2.02%

+$0.08 today

Market cap
$125.90M
Beta
1.20
P/E (TTM)
-3.6
EPS (TTM)
-$1.11
52W Low $1.19High $4.64

Volume 0.72M

Average 0.98M

MGNX Other Non-current Liabilities

Long-term obligations not reported separately, such as lease or pension liabilities.

MacroGenics, Inc.NASDAQ: MGNX

Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Other non-current liabilities rises 3428.5% from a year ago

Other non-current liabilities stood at $69.44M at the end of Q1 FY2026, up 3428.5% from a year earlier and up 6500.8% from the prior quarter. Over 3 fiscal years it compounded at +59.8% a year.

Context

  • Other non-current liabilities amounted to 31.9% of total assets at the end of Q1 FY2026, up 31.0 pp from a year earlier.
  • Other non-current liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +3428.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$69.44M+6500.8% QoQ
Last fiscal yearDec 2025
$1.05M-46.5% YoY
Year agoMar 2025
$1.97M+3428.5% since
Other Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3428.5%——
1 year-46.5%——
3-year CAGR+59.8%——
5-year CAGR——
10-year CAGR——

Other Non-current Liabilities history

USD · from the balance sheet

Latest · FY2025
1.05M USD
Year-over-year change
-46.5%
4-year CAGR
+42.1%

Other Non-current Liabilities vs competitors

How MGNX compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +3428.5% is the 2nd highest of 7, against a peer median of +217.6%.
  • Other non-current liabilities amounts to 31.9% of total assets for MGNX, versus a peer median of 0.1%.
MGNX Competitors
Other Non-current Liabilities for MGNX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MGNXMacroGenics, Inc.Mar 2026$69.44M USD+3428.5%+59.8%31.9%
CLNNClene Inc.Mar 2026$14.39M USD+435.2%+47.2%66.4%
OVIDOvid Therapeutics Inc.Mar 2026$11.61M USD+1161000.0%—5.1%
ZNTLZentalis Pharmaceuticals, Inc.Mar 2026$500K USD-10.4%-42.4%0.2%
ORMPOramed Pharmaceuticals Inc.Mar 2026$238K USD+621.2%+56.4%0.1%
CNTBConnect Biopharma Holdings LimitedDec 2025$114K USD-82.0%—0.2%
IFRXInflaRx N.V.Mar 2026€36.92K EUR+0.1%-0.0%0.1%
STTKShattuck Labs, Inc.Mar 2026$0 USD——0.0%
WHWKWhitehawk Therapeutics IncMar 2026$0 USD——0.0%
COYACoya Therapeutics, Inc.Mar 2026$0 USD——0.0%
CNTXContext Therapeutics Inc.Mar 2026$0 USD——0.0%
Peer median (excluding MGNX) —+217.6%+23.6%0.1%

Competitors are the stored peer set for MGNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents123.47M108.88M100.96M182.84M57.22M
Short-term Investments120.15M45.46M128.85M18.83M132.7M
Net Receivables10.39M56.22M10.37M4.31M13.37M
Inventory4.39M1.45M1.22M07.91M
Other Current Assets010.16M9.95M11.51M8.75M
Total Current Assets279.56M222.18M251.34M217.49M219.94M
Property, Plant & Equipment (Net)54.29M56.91M45.69M42.61M35.52M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets09.04M000
Other Non-current Assets1.4M1.38M1.39M10.46M1.39M
Total Non-current Assets55.69M67.33M47.08M53.07M36.91M
Total Assets335.25M289.51M298.42M261.66M256.85M
Account Payables15.5M4.9M6.44M5.01M4.79M
Short-term Debt04.73M005.18M
Tax Payables00000
Deferred Revenue09.99M21.65M16.32M10.92M
Other Current Liabilities20.65M29M0022.23M
Total Current Liabilities74.58M48.61M56.11M55.53M43.12M
Long-term Debt000070M
Deferred Tax Liabilities09.04M08.9M0
Deferred Revenue (Non-current)059.48M59.24M55.5M55.5M
Other Non-current Liabilities258K258K258K1.97M1.05M
Total Non-current Liabilities21.05M98.89M89.7M98.97M158.14M
Total Liabilities95.63M147.5M145.81M145.6M201.26M
Common Stock613K617K621K628K633K
Retained Earnings(973.94M)(1.09B)(1.1B)(1.17B)(1.24B)
Accumulated OCI(61K)(5K)(6K)4K32K
Other Stockholders Equity(0)0000
Minority Interest00000
Total Equity239.62M142.01M152.61M116.06M55.59M
Total Debt25.47M34.83M33.97M37.46M106.76M
Net Debt(98M)(74.05M)(66.99M)(145.38M)49.55M

MacroGenics, Inc.

NASDAQ:MGNX

Intrinsic Alpha fair value

Locked

Current Price

$1.97

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.